Vaccine and antiviral R&D underway for rare Bundibugyo Ebola outbreak (bioworld.com)

• Animal studies for Bundibugyo Ebola vaccine started in U.S. and U.K.
• Serum Institute of India prepared to manufacture for clinical trials
• Clinical trials expected in 2–3 months if animal results positive

"Less than two weeks after the outbreak was officially declared, animal studies of a newly designed vaccine against the Bundibugyo Ebola virus are underway in the U.S. and U.K. The Serum Institute of India is ready to manufacture the vaccine for clinical trials. If animal tests are positive, the vaccine will be ready for clinical trials in two to three months."